Patents
Patents for C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
06/2005
06/28/2005US6911457 Diabetes imaging probes
06/28/2005US6911439 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents
06/23/2005WO2005057171A2 Protein-protein interaction antagonist screening libraries based upon 1,4-disubstituted naphthalenes and related scaffolds
06/23/2005WO2005055715A2 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives
06/23/2005US20050137190 Compositions useful as inhibitors of voltage-gated sodium channels
06/22/2005EP1543148A1 Method and probe for identifying bacterial virulence modifying agents, agents thus identified, and their use
06/22/2005EP1542667A2 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
06/21/2005US6908937 Heterocyclic fluoroalkenyl thioethers (II)
06/21/2005US6908935 Calcium receptor modulating agents
06/21/2005US6908492 Cationic hair dyes; colorfastness, photostability
06/16/2005WO2005054430A2 Hepatitis c virus inhibitors
06/16/2005WO2005054218A1 Nitrooxyderivatives of antihypertensive drugs
06/16/2005WO2005025293A3 Fused ring heterocycles as potassium channel modulators
06/16/2005US20050130979 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) or the quinoxalinedione is 9-methyl-amino-6-nitro-hexahydro-benzo(F) quinoxalinedione (PNQX) for treating demyelinating disorders
06/16/2005CA2548127A1 Nitrooxyderivatives of antihypertensive drugs
06/15/2005EP1541150A1 Use of methylol transfer agents for treatment of mesothelioma
06/15/2005EP1222194B1 7-acylamino-3-heteroarylthio-3-cephem carboxylic acid antibiotics and prodrugs thereof
06/15/2005EP1165070B1 Thiadiazolyl urea or thiourea derivatives for antiviral treatment
06/15/2005CN1206231C 7-acylamino-3-heteroarylthio-3-cephem carboxylic and prodrugs thereof
06/14/2005CA2304967C 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
06/09/2005WO2005051932A1 Arylheterocycle derivative and agricultural or horticulrual bactericide and insecticide
06/09/2005US20050124664 Compounds for treatment of cardiovascular disorders using inhibitors of plasmnogen activator as anticoagulants for blood
06/09/2005US20050124656 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps)
06/09/2005US20050124654 Compounds and methods of use
06/09/2005US20050124609 Orally administering to a patient a methylol transfer agent; e.g., an oral dose of about 100-1000 mg. of taurolidine, taurultam or mixtures; ulcerative colitis; Crohn's disease; reduces side effects when administered with other drugs; synergistic; bactericides; endotoxins; antiinflammatory agents
06/09/2005US20050124606 Novel benzothiazine and benzothiadiazine derivatives method for preparing same and pharmaceutical compositions containing same
06/09/2005US20050123831 used for ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions
06/08/2005EP1537077A2 4-(3,3-dihalo-allyloxy) phenol derivatives having pesticidal properties
06/08/2005EP1536784A1 Hetero biaryl derivatives as matrix metalloproteinase inhibitors
06/08/2005CN1623537A Biaryl sulfonamides and its using method
06/07/2005US6903097 Heterocycle carboxamides as antiviral agents
06/07/2005US6903088 Compounds which inhibit leukocyte adhesion mediated by VLA-4
06/02/2005WO2005049546A1 Halogenated bisdiarylaminopolycylic aromatic compounds and polymers thereof
06/02/2005WO2004033440A8 Thiadiazoledioxides and thiadiazoleoxides as cxc- and cc-chemokine receptor ligands
06/02/2005US20050119467 Azo dye
06/02/2005US20050119254 Antitumor agents; using taurolidine; administering into lungs
06/01/2005EP1535909A2 Cyclic amine derivatives and their use as drugs
06/01/2005EP1534273A2 Modulators of the glucocorticoid receptor and method
05/2005
05/31/2005US6900218 Reducing oxidation stresses; central nervous system disorders; antiinflammatory agents
05/26/2005US20050113520 used in optical telecommunications devices such as waveguides; monomers such as 2,4,6-tris(4-ethenyl-2,3,5,6-tetrafluorophenyl)-1,3,5-triazine
05/25/2005EP1533303A1 Substituted Aminosalicylacid Amides ( intermediates )
05/25/2005EP1532128A1 Inhibitors of hcv ns5b polymerase
05/25/2005EP1531815A1 Glucokinase activators
05/25/2005DE10352082A1 Hexylcarboxanilide Hexylcarboxanilides
05/19/2005WO2005019191A3 1, 1-dioxido-4h-1,2,4-benzothiadiazine derivate und verwandte verbindungen als inhibitoren der hcv polymerase zur behandlung von hepatitis c
05/19/2005US20050107616 Alpha-ketoamide derivatives as cathepsin k inhibitors
05/19/2005US20050107364 Viricides for infections caused by an RNA-containing virus; enzyme inhibitors for a hepatitis C virus (HCV) polymerase; inhibiting HCV viral replication; liver cirrhosis; e. g., 3-(1,1-dioxido-4H-1,2,4-benzothiadiazin-3-yl)-4-hydroxy-1,1-dipropyl-2(1H)-naphthalenone
05/18/2005CN1617864A Thiadiazoline derivative
05/18/2005CN1617863A Thiadiazole compounds and use thereof
05/18/2005CN1617862A Novel 1, 2, 4-thiadiazole derivatives as melanocortin receptor modulators
05/18/2005CN1617852A Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
05/18/2005CN1202097C Benzothiadiazole compound and application in plant cell thereof
05/18/2005CN1202095C Heteroaromatic ring compounds
05/17/2005US6894054 Central nervous system disorders; muscular disorders
05/17/2005US6894043 Benzothiadiazine derivatives, preparation method and pharmaceutical compositions containing same
05/17/2005US6893650 Fungicides; locus infestation; such as N,N-dimethyl-N'-(4-(3-trifluoromethylbenzylthio)-2,5-xylyl)formamidine
05/12/2005WO2005042493A1 Hexyl carboxanilides and their use for controlling undesirable micro-organisms
05/12/2005WO2005041959A1 Phenoxyacetic acids derivatives useful as peroxisome proliferator-activated receptor (ppar) dual agonists
05/12/2005WO2005021490A3 N-SULFONYL-α-AMINO-ACID DERIVATIVES
05/12/2005WO2005000231A3 Il-8 receptor antagonists
05/12/2005WO2004022775A8 Method and probe for identifying bacterial virulence modifying agents, agents thus identified, and their use
05/12/2005US20050101779 Antagonistic activity to alpha 4 integrin; antiinflammatory agents treating asthma, rheumatoid arthritis, inflammatory bowel diseases, lupus, diabetes; 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl(2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[4-[1-methyl-2,4-dioxo-1,4-tetrahydro-3-(2H)quinazolinyl]phenyl]Propionate
05/12/2005US20050101646 Tyrosine kinase inhibitor; antiproliferative agents; controlling signal transduction; anticancer agents
05/12/2005CA2544317A1 Phenoxyacetic acids derivatives useful as peroxisome proliferator-activated receptor (ppar) dual agonists
05/11/2005EP1529816A1 Azo dye
05/11/2005EP1529530A1 Compounds affecting glucokinase
05/11/2005EP1309563B1 Heterocyclic-hydroxyimino-fluorenes and their use for inhibiting protein kinases
05/11/2005EP0951464B1 N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
05/10/2005US6891071 Halogenated styrene compounds and very low-loss polymers made therefrom
05/10/2005US6890942 Acyl sulfonamides as inhibitors of HIV integrase
05/06/2005WO2005040101A1 Acylurea connected and sulfonylurea connected hydroxamates
05/06/2005WO2005040100A1 Tetrahydro-naphthalene and urea derivatives
05/06/2005WO2005005395A3 Arylamine-substituted quinazolinone compounds
05/06/2005WO2004092116A8 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
05/06/2005CA2543570A1 Acylurea connected and sulfonylurea connected hydroxamates
05/06/2005CA2542494A1 Tetrahydro-naphthalene and urea derivatives
05/05/2005US20050096404 Formed from mesogen such as 2,7-bis{5-[4-(8-diallylaminooctyloxy)phenyl]-thien-2-yl}-9,9-dipropylfluorene; photopolymerization without photoinitiator; lowcost, bright, portable displays; simple manufacturing, enhanced power and transmission efficiency; does not require polarizer
05/05/2005US20050096362 4-((Phenoxyalkyl)thio)-phenoxyacetic acids and analogs
05/04/2005EP1341539B1 Anti-inflammatory agents
05/04/2005CN1612869A Novel 1, 2, 4-thiadiazolium derivatives as melanocortin receptor modulators
05/04/2005CN1612057A Organophotoreceptor with charge transport material having fluorenone hydrazone groups
05/03/2005CA2276741C Dithiocarbamate derivatives and lubricants containing same
04/2005
04/28/2005WO2005037844A1 Substituted phenyl fused heterocycles as high efficiency herbicides
04/28/2005WO2005037805A2 1,2,4-thiadiazole compounds and pests controlling composition containing the same
04/28/2005WO2004014844A3 Aryl and heteroaryl compounds and methods to modulate coagulation
04/28/2005US20050090630 Supported group 8-10 transition metal olefin polymerization catalysts
04/28/2005US20050090502 Protein tyrosine phosphatase 1B inhibitors alone or incombination with other antidiabetic, antilipemic, anticholesterol or hypotensive agents
04/27/2005CN1609110A High efficiency substituted benzene fused heterocycle herbicides
04/26/2005US6884265 A stable direct dyes, hair dyes, like oxidation color dyes, chemical resistance, photostability, weatherproofing, wash and wear; comprising imidazolinium, triazolium and pyridinium groups
04/26/2005CA2213124C Benzoyl derivatives
04/21/2005WO2005035512A1 Thiadiazoline derivatives
04/21/2005WO2004062601A3 Antibacterial agents
04/21/2005US20050085523 Imidazolyl and pyrazolyl ethyne compounds
04/21/2005CA2542034A1 Thiadiazoline derivatives
04/20/2005CN1608065A Phenyl substituted triazoles and their use as selective inhibors of akl5 kinase and pharmaceutical compositions containing the compounds
04/14/2005US20050080119 Diaminopropionic acid derivatives
04/14/2005US20050080106 Such as 2-[3,5-Di(2-chlorobenzyloxy)benzoyl)amino]-thiazole; for treatment of diabetes
04/14/2005US20050080072 Such as 11-[4-[2-(2-hydroxyethoxy)ethyl]-1-pinerazinyl]dibenzo[b,f][1,4]thiazepine (quetiapine) via reduction, cyclization, and deprotection
04/14/2005US20050079456 Forms an azomethine dye upon a coupling reaction with an oxidized product of a developing agent; excellent in color reproducibility and image storability
04/13/2005EP1522899A2 Organophotorecpetor with charge transport material having fluorenone hydrazone groups
1 ... 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 ... 100